Reply to “Comment on ‘Quantifying Benefit-Risk Trade-Offs Toward Prophylactic Treatment Among Adult Patients with Hemophilia A in China: Discrete Choice Experiment Study’ ”from Li et al. (Preprint)
Author:
Wang Limin,
Liu Shimeng,
Jiang Shan,
Li Chaofan,
Lu Liyong,
Fang Yunhai,
Li ShunpingORCID
Abstract
INTERNATIONAL REGISTERED REPORT
RR2-10.2196/45747
Publisher
JMIR Publications Inc.